Evidence map›Paper›PMID 38725255›Full record

ReviewWiley interdisciplinary reviews. Nanomedicine and nanobiotechnology

Life at the interface: Engineering bio-nanomaterials through interfacial molecular self-assembly.

Michael A Miller, Scott Medina

Abstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Michael A MillerDepartment of Biomedical Engineering, Pennsylvania State University, University Park, Pennsylvania, USA.ORCID 0009-0001-9213-2419
Scott MedinaDepartment of Biomedical Engineering, Pennsylvania State University, University Park, Pennsylvania, USA.ORCID 0000-0001-5441-2164

Funding

Understanding and controlling the cellular fate of fluorine-modified biologicsR35GM142902 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI Scott Hammond Medina · 2021 to 2026
$2.2M
Biomimetic Peptide Aerosols for Rapid Clearance of Pulmonary MDR TuberculosisR01AI165996 · NIAID · PENNSYLVANIA STATE UNIVERSITY, THE · PI Scott Hammond Medina · 2022 to 2026
$2.2M
Ultrasound-programmable gene editing in kidneysR21DK128638 · NIDDK · PENNSYLVANIA STATE UNIVERSITY, THE · PI MEDINA, SCOTT HAMMOND · 2021 to 2022
$379k
NIAID NIH HHS R01 AI165996NIDDK NIH HHS 1R21-DK128638NIDDK NIH HHS R21 DK128638NIGMS NIH HHS 1R35-GM142902NIGMS NIH HHS R35 GM142902
6 · The paper itself

Abstract

Interfacial self-assembly describes the directed organization of molecules and colloids at phase boundaries. Believed to be fundamental to the inception of primordial life, interfacial assembly is exploited by a myriad of eukaryotic and prokaryotic organisms to execute physiologic activities and maintain homeostasis. Inspired by these natural systems, chemists, engineers, and materials scientists have sought to harness the thermodynamic equilibria at phase boundaries to create multi-dimensional, highly ordered, and functional nanomaterials. Recent advances in our understanding of the biophysical principles guiding molecular assembly at gas-solid, gas-liquid, solid-liquid, and liquid-liquid interphases have enhanced the rational design of functional bio-nanomaterials, particularly in the fields of biosensing, bioimaging and biotherapy. Continued development of non-canonical building blocks, paired with deeper mechanistic insights into interphase self-assembly, holds promise to yield next generation interfacial bio-nanomaterials with unique, and perhaps yet unrealized, properties. This article is categorized under: Nanotechnology Approaches to Biology > Nanoscale Systems in Biology Therapeutic Approaches and Drug Discovery > Emerging Technologies.

Indexed as

NanostructuresNanotechnologyAnimalsHumansbiomaterialsinterfacenanomedicineself‐assembly

Identifiers

PMID38725255
PMCPMC11090466

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.